Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1990
Pharmacokinetics of a novel butylated hydroxytoluene-thiazolidinone CNS antiischemic agent LY256548 in rats, mice, dogs, and monkeysK J Ruterbories, T D LindstromThe Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Pharmacokinetics and disposition of the KS1/4 monoclonal antibody-desacetylvinblastine hydrazide conjugate LY203725 in rats and monkeysT D Lindstrom, W A Althaus, K J Ruterbories, et al.Bioanalysis|April 11, 2023
Signature peptide selection workflow for biomarker quantification using LC-MS-based targeted proteomicsXiazi I Qiu, Kenneth J Ruterbories, Qin C Ji, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 11, 2015
In vitro characterization of the bioconversion of pomaglumetad methionil, a novel metabotropic glutamate 2/3 receptor agonist peptide prodrugRichard D Moulton, Kenneth J Ruterbories, David W Bedwell, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 12, 2017
Development of a rapid and sensitive multiple reaction monitoring proteomic approach for quantification of transporters in human liver tissueLi Wang, Kasi J Rubadue, Jeffrey Alberts, et al.Bioanalysis|February 21, 2022
Comparison of three parallelism assessment methods of biomarker quantification by LC-MS/MS: a case study of the bioanalysis of creatinine in human urine samplesXiazi I Qiu, John P Savaryn, Kenneth J Ruterbories, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 9, 2013
High sensitive assay employing column switching chromatography to enable simultaneous quantification of an amide prodrug of gemcitabine (LY2334737), gemcitabine, and its metabolite dFdU in human plasma by LC-MS/MSEnaksha R Wickremsinhe, Lisa B Lee, Chris A Schmalz, et al.Analytical Chemistry|June 7, 2011
Statistical method for quantifying mobile phase selectivity in one- and two-dimensional overpressured layer chromatographyD Nurok, R M Kleyle, C L McCain, et al.Journal of Pharmacological and Toxicological Methods|December 17, 2002
A novel testosterone 6 beta-hydroxylase activity assay for the study of CYP3A-mediated metabolism, inhibition, and induction in vitroJ L Fayer, D M Petullo, B J Ring, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 4, 2016
The Impact of the Hepatocyte-to-Plasma pH Gradient on the Prediction of Hepatic Clearance and Drug-Drug Interactions for CYP2D6 SubstratesLuc R A Rougée, Michael A Mohutsky, David W Bedwell, et al.Pageof 3